Deciphera Pharmaceuticals
The Director, Regulatory Affairs will develop and implement global regulatory strategies for oncology programs from early development through post-marketing. This role provides expert guidance to cross-functional teams, drives regulatory submissions, and ensures compliance with applicable regulations and industry standards. The position involves leading regulatory submissions, collaborating with clinical and development teams, and mentoring regulatory affairs staff.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
Director, Regulatory Affairs
Kura Oncology
Associate Director, Global Regulatory Affairs, Compliance
Olema Oncology
Regulatory Affairs Director
AstraZeneca
Regulatory Affairs Lead
BeOne Medicines
Director, Global Regulatory Strategy Lead - Regulatory Affairs
Olema Oncology
Regulatory Affairs Director
AstraZeneca